Similar articles

• A neurobiological model for the symmetrical prophylactic action of lithium in bipolar affective disorder.

  Mandell AJ, Knapp S. Mandell AJ, et al. Pharmakopsychiatr Neuropsychopharmakol. 1976 May;9(3):116-26. doi: 10.1055/s-0028-1094486. Pharmakopsychiatr Neuropsychopharmakol. 1976. PMID: 988597
• Alterations in brain 5-hydroxytryptamine metabolism during the 'withdrawal' phase after chronic treatment with diazepam and bromazepam.

  Agarwal RA, Lapierre YD, Rastogi RB, Singhal RL. Agarwal RA, et al. Br J Pharmacol. 1977 May;60(1):3-9. doi: 10.1111/j.1476-5381.1977.tb16740.x. Br J Pharmacol. 1977. PMID: 18243 Free PMC article.
• Current research in the indoleamine hypothesis of affective disorders.

  Mandell AJ, Knapp S. Mandell AJ, et al. Psychopharmacol Commun. 1975;1(6):587-97. Psychopharmacol Commun. 1975. PMID: 1241455
• 5-hydroxytryptamine metabolism in the brain under the influence of psychotropic drugs.

  Herman ZS. Herman ZS. Pol J Pharmacol Pharm. 1975 Oct;27(Suppl):25-43. Pol J Pharmacol Pharm. 1975. PMID: 128747 Review. No abstract available.
• Use of serotonergic agents in the clinical assessment of central serotonin function.

  Murphy DL, Mueller EA, Garrick NA, Aulakh CS. Murphy DL, et al. J Clin Psychiatry. 1986 Apr;47 Suppl:9-15. J Clin Psychiatry. 1986. PMID: 3514586 Review.